Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

Abstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers...

Full description

Bibliographic Details
Main Authors: John Greenwood, Margareta Hammarlund-Udenaes, Hazel C. Jones, Alan W. Stitt, Roosmarijn E. Vandenbroucke, Ignacio A. Romero, Matthew Campbell, Gert Fricker, Birger Brodin, Heiko Manninga, Pieter J. Gaillard, Markus Schwaninger, Carl Webster, Krzysztof B. Wicher, Michel Khrestchatisky
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Fluids and Barriers of the CNS
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12987-017-0079-9
id doaj-9f2b405af0e144599c2986f71ecc7708
record_format Article
spelling doaj-9f2b405af0e144599c2986f71ecc77082020-11-25T00:38:56ZengBMCFluids and Barriers of the CNS2045-81182017-11-0114111110.1186/s12987-017-0079-9Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood0Margareta Hammarlund-Udenaes1Hazel C. Jones2Alan W. Stitt3Roosmarijn E. Vandenbroucke4Ignacio A. Romero5Matthew Campbell6Gert Fricker7Birger Brodin8Heiko Manninga9Pieter J. Gaillard10Markus Schwaninger11Carl Webster12Krzysztof B. Wicher13Michel Khrestchatisky14Institute of Ophthalmology, University College LondonDepartment of Pharmaceutical Biosciences, Uppsala UniversityGagle Brook House, ChestertonCentre for Experimental Medicine, Queen’s University BelfastDepartment of Biomedical Molecular Biology, Ghent UniversitySchool of Life, Health and Chemical Sciences, Open UniversitySmurfit Institute of Genetics, Lincoln Place Gate, Trinity College DublinInstitute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls UniversityDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of CopenhagenNEUWAY Pharma GmbH2-BBB Medicines BVInstitute of Experimental and Clinical Pharmacology and Toxicology, University of LübeckAntibody Discovery and Protein Engineering, MedImmuneOssianix Inc.CNRS, NICN, Aix Marseille UnivAbstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.http://link.springer.com/article/10.1186/s12987-017-0079-9Blood–brain barrierBlood–CSF barrierBlood–retinal barrierNeuroinflammationViral vectorsDrug delivery
collection DOAJ
language English
format Article
sources DOAJ
author John Greenwood
Margareta Hammarlund-Udenaes
Hazel C. Jones
Alan W. Stitt
Roosmarijn E. Vandenbroucke
Ignacio A. Romero
Matthew Campbell
Gert Fricker
Birger Brodin
Heiko Manninga
Pieter J. Gaillard
Markus Schwaninger
Carl Webster
Krzysztof B. Wicher
Michel Khrestchatisky
spellingShingle John Greenwood
Margareta Hammarlund-Udenaes
Hazel C. Jones
Alan W. Stitt
Roosmarijn E. Vandenbroucke
Ignacio A. Romero
Matthew Campbell
Gert Fricker
Birger Brodin
Heiko Manninga
Pieter J. Gaillard
Markus Schwaninger
Carl Webster
Krzysztof B. Wicher
Michel Khrestchatisky
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
Fluids and Barriers of the CNS
Blood–brain barrier
Blood–CSF barrier
Blood–retinal barrier
Neuroinflammation
Viral vectors
Drug delivery
author_facet John Greenwood
Margareta Hammarlund-Udenaes
Hazel C. Jones
Alan W. Stitt
Roosmarijn E. Vandenbroucke
Ignacio A. Romero
Matthew Campbell
Gert Fricker
Birger Brodin
Heiko Manninga
Pieter J. Gaillard
Markus Schwaninger
Carl Webster
Krzysztof B. Wicher
Michel Khrestchatisky
author_sort John Greenwood
title Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_short Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_full Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_fullStr Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_full_unstemmed Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_sort current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on cns barrier congress london, uk, 2017
publisher BMC
series Fluids and Barriers of the CNS
issn 2045-8118
publishDate 2017-11-01
description Abstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.
topic Blood–brain barrier
Blood–CSF barrier
Blood–retinal barrier
Neuroinflammation
Viral vectors
Drug delivery
url http://link.springer.com/article/10.1186/s12987-017-0079-9
work_keys_str_mv AT johngreenwood currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT margaretahammarlundudenaes currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT hazelcjones currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT alanwstitt currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT roosmarijnevandenbroucke currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT ignacioaromero currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT matthewcampbell currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT gertfricker currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT birgerbrodin currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT heikomanninga currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT pieterjgaillard currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT markusschwaninger currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT carlwebster currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT krzysztofbwicher currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT michelkhrestchatisky currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
_version_ 1725295768595595264